Comments
GlaxoSmithKline Consumer Healthcare (GSK) Ltd posted a net profit of ₹285.81 crore in the fourth quarter ended March 31, 2019 — up 34.9 per cent compared to ₹211.81 crore in the same quarter previous fiscal. Revenue grew by 9 per cent to ₹1,286 crore in the fourth quarter.
“The Board of Directors of the Company recommended a dividend at the rate of ₹105 per equity share of ₹10 each for the year ended March 31, 2019,” the company said in a statement.
In FY 2018-19, the company posted a net profit of ₹982.80 crore — up 40.3 per cent over ₹700.10 crore in the previous fiscal. For the full year, the revenues of the company grew by 9.25 per cent to ₹4,782 crore.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.